Title : Targeted Drug Delivery and Theranostic Strategies in Malignant Lymphomas.

Pub. Date : 2022 Jan 26

PMID : 35158894






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The first clinically approved TDD modalities in lymphoma patients were anti-CD20 radioimmunoconjugates (RIT) 131I-tositumomab and 90Y-ibritumomab-tiuxetan. 2-(4-isothiocyanatobenzyl)-6-methyldiethylenetriaminepentaacetic acid keratin 20 Homo sapiens